Governors Push FDA For Guidance On Biotech Generics

Law360, New York (August 7, 2006, 12:00 AM EDT) -- The governors of four states have petitioned the U.S. Food and Drug Administration to provide clear guidance on how to get generic versions of human growth hormone (HGH) and insulin, two biotechnology medications, to the market.

“Petitioners also are vitally interested in ensuring that high-quality, affordable health care is available to all citizens of their states who are not covered by a state prescription drug benefit and ensuring that pharmaceutical costs are as low as possible,” stated the bipartisan group of Govs. James Douglas (R-Vt.), Jim...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.